The FTSE 100 has made some considerable gains since Rishi Sunak came to office, despite ongoing challenges relating to inflation and a forecast recession.
And despite this environment, research from the Economic Forecast Agency (EFA) suggests that the FTSE 100 could push as high as 8,588 in March. This would represent a 13% increase from current levels. That would be nice.
However, this is the upper end of the EFA’s forecast. The research group contends that the index would likely close around 8,102 at the end of March. That’s still 9% above where it is today.
Upward pressure
The EFA is clearly pretty optimistic about near-term prospects for the FTSE 100. And so am I actually.
This year, the index has fallen and recovered to around 7,500. But it’s been an uneven recovery. We’ve seen oil and resource stocks surge — these company’s are disproportionately represented on the FTSE 100.
But other sectors have suffered, such as housebuilding, retail, manufacturing, and banking, all fairing poorly by comparison to resource stocks.
And as investors, we’re often trying to assess what the market will look like in six-to-12 months. So while the coming months might look pretty bleak, I can see why investors might have a much more optimistic outlook in March.
By spring, I’m hoping the end of the recession will be in sight.
Recovery picks
So with the market possibly poised to recover, I’m looking at two stocks from underperforming sectors.
My first pick is Spire Healthcare (LSE:SPI). Medical stocks have underperformed since the start of the pandemic. There are several reasons for this, but first among them is the Covid-related disruption. National resources were put towards treating the pandemic, not replacing hips, and the virus caused costly cancelations.
But things are looking up for Spire. In September, the private hospital operator said revenues in the six months to 30 June had risen 7% to £597.9m, while adjusted EBITDA was ahead 10.2% at £105.8m.
The firm, which has 39 private hospitals and eight clinics, said there was “significantly increased demand for healthcare, with 6.7m people nationally awaiting treatment“.
The economic environment could negatively impact demand in the near term. However, I do see demand for healthcare as being less elastic than other services. That’s why I’ve recently bought more shares in Spire Healthcare.
My second pick is Hargreaves Lansdown. This stock has suffered in 2022. Growth unsurprisingly slowed following the unique pandemic-induced environment and the cost-of-living crisis may cause investors to reduce their investments.
However, looking further afield, Hargreaves is well placed to take advantage of trends. Notably more people investing, and more people taking control of their own investments. The supermarket for funds and stocks is already the UK’s most used platform and, in my opinion, for good reason.
I’ve recently bought more Hargreaves stock for my portfolio.
The post FTSE 100 to surge above 8,500 in early 2023? 2 cheap stocks to buy before the recovery appeared first on The Motley Fool UK.
Should you buy Hargreaves Lansdown shares today?
Before you decide, please take a moment to review this first.
(Even if you weren’t born before 1972.)
Because The Motley Fool’s top UK analysts have revealed: ‘5 Stocks for Trying to Build Wealth After 50’. And you can grab this report, absolutely free.
In our opinion, it’s never too late to build wealth with shares. Indeed, with markets down this may be an ideal time to start.
And while past performance is not an indicator of future results, history has shown that after shares fall by 20%, there’s a 90% chance they’ll be higher within 5 years.
When they do, the average return has been 61%.*
So while there are no guarantees, our analyst team have a habit record of finding such opportunities. In 10 minutes, this free report brings you up to speed .
See the 5 stocks
* Source: Robert Shiller, Economist – Yale University. Figures based on historic US market data from 1871 – Present, with additional calculations by The Motley Fool.
setButtonColorDefaults(“#5FA85D”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43A24A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#ffffff”, ‘color’, ‘#fff’);
})()
More reading
FTSE 100 stocks in focus: should I buy Hargreaves Lansdown or abrdn?
3 FTSE 100 shares to buy now, after 35% falls in 2022?
1 of the best high yield UK stocks to buy today… and 1 to avoid
Cheap shares: 1 stock I’d buy in 2023 and hold for a decade
Best British growth stocks to buy for December
James Fox has positions in Hargreaves Lansdown Plc and Spire Healthcare Group Plc. The Motley Fool UK has recommended Hargreaves Lansdown Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.